- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Buy the Dip
Global Pharmaceuticals & Biotech Buy the Dip
Results
39
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
39 companies
CSPC Pharmaceutical Group
Market Cap: HK$103.9b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.09
7D
-8.6%
1Y
60.9%
ACADIA Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.05
7D
-13.8%
1Y
34.2%
Hybio Pharmaceutical
Market Cap: CN¥18.5b
Engages in the development, manufacture, and commercialization of therapeutic peptides API and peptide-based drugs in China and internationally.
300199
CN¥20.96
7D
-13.2%
1Y
100.6%
CanSino Biologics
Market Cap: HK$15.8b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$46.96
7D
-9.0%
1Y
94.9%
Liquidia
Market Cap: US$1.9b
A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
LQDA
US$21.80
7D
-8.3%
1Y
117.8%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$13.5b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$1.47
7D
-9.8%
1Y
153.4%
Lepu Biopharma
Market Cap: HK$12.6b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of first-in class and best-in-class drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally.
2157
HK$7.01
7D
-8.4%
1Y
100.9%
HBM Holdings
Market Cap: HK$11.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$14.01
7D
-8.8%
1Y
961.4%
Beijing Sun-Novo Pharmaceutical Research
Market Cap: CN¥7.3b
A contract research company, engages in the research and development of drugs in China.
688621
CN¥66.66
7D
-13.4%
1Y
83.7%
Idorsia
Market Cap: CHF 777.6m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 3.65
7D
-9.6%
1Y
128.0%
Shanxi Zhendong PharmaceuticalLtd
Market Cap: CN¥6.5b
Engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally.
300158
CN¥6.57
7D
-10.7%
1Y
69.3%
Pharming Group
Market Cap: €770.8m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.13
7D
-10.0%
1Y
44.4%
Aarti Pharmalabs
Market Cap: ₹74.7b
Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.
AARTIPHARM
₹824.05
7D
-11.4%
1Y
33.8%
UroGen Pharma
Market Cap: US$832.3m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$17.26
7D
-8.5%
1Y
35.4%
ChemPartner PharmaTechLtd
Market Cap: CN¥5.7b
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide.
300149
CN¥11.41
7D
-10.1%
1Y
87.7%
Thalys Medical Technology Group
Market Cap: CN¥4.8b
Provides intensive operation services of medical inspection in China.
603716
CN¥25.65
7D
-10.8%
1Y
297.1%
Gossamer Bio
Market Cap: US$632.1m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
GOSS
US$2.70
7D
-11.5%
1Y
181.3%
Organogenesis Holdings
Market Cap: US$593.7m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$4.10
7D
-10.5%
1Y
41.9%
Rigel Pharmaceuticals
Market Cap: US$514.8m
A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.
RIGL
US$28.63
7D
-17.5%
1Y
74.4%
SMO ClinPlusLTD
Market Cap: CN¥3.6b
Provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China.
301257
CN¥45.85
7D
-10.6%
1Y
58.1%
Hua Medicine (Shanghai)
Market Cap: HK$3.8b
Engages in the development and commercialization of drugs for the treatment of diabetes in China.
2552
HK$3.85
7D
-9.8%
1Y
191.7%
Lifecore Biomedical
Market Cap: US$254.9m
Operates as an integrated contract development and manufacturing organization in the United States.
LFCR
US$7.01
7D
-10.9%
1Y
41.6%
3D Medicines
Market Cap: HK$1.8b
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.
1244
HK$7.31
7D
-9.8%
1Y
139.7%
JW (Cayman) Therapeutics
Market Cap: HK$1.7b
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$4.10
7D
-17.7%
1Y
159.5%
Sirnaomics
Market Cap: HK$1.5b
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.
2257
HK$14.46
7D
-11.7%
1Y
322.8%
Synbio Tech
Market Cap: NT$4.2b
Manufactures and sells human healthcare products and probiotics for animals.
1295
NT$122.00
7D
-9.0%
1Y
33.3%
Thor Medical
Market Cap: NOK 1.3b
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 3.65
7D
-16.4%
1Y
212.5%
HansBiomed
Market Cap: ₩170.9b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩13,160.00
7D
-17.6%
1Y
32.1%
Shield Therapeutics
Market Cap: UK£76.4m
A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.
STX
UK£0.072
7D
-10.0%
1Y
50.0%
Alterity Therapeutics
Market Cap: AU$103.3m
Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.
ATH
AU$0.0095
7D
-13.6%
1Y
137.5%
Quantum BioPharma
Market Cap: CA$92.5m
Operates as a biopharmaceutical company.
QNTM
CA$22.18
7D
-14.7%
1Y
342.7%
Ascelia Pharma
Market Cap: SEK 402.0m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 3.47
7D
-11.3%
1Y
50.7%
NeuroScientific Biopharmaceuticals
Market Cap: AU$54.9m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.17
7D
-8.3%
1Y
385.3%
ProBiotix Health
Market Cap: UK£10.7m
Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.
PBX
UK£0.068
7D
-12.9%
1Y
58.8%
Abera Bioscience
Market Cap: SEK 104.4m
A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.
ABERA
SEK 6.80
7D
-12.8%
1Y
70.0%
Genetic Analysis
Market Cap: NOK 60.8m
A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.
GEAN
NOK 0.88
7D
-15.4%
1Y
31.3%